EZZ Life Science Holdings Limited
EZZ
Rank in Stocks
#28708
EZZ Life Science Holdings Limited, an Australian company, specializes in... EZZ Life Science Holdings Limited, an Australian company, specializes in offering a range of skincare and consumer health products, with its market presence extending across Australia, New Zealand, Mainland China, and other international territories. The company's operations are divided into two distinct segments: 'Brought in Lines' and 'Company Owned products.' EZZ is actively involved in the wholesale supply of its EAORON-branded skincare portfolio, distributing it to pharmacies, major supermarkets, specialist retailers, and general grocery stores. Furthermore, the company designs, develops, manufactures, and markets a comprehensive selection of consumer health products under its own EZZ brand. This extensive offering includes vitamins, dietary supplements, sports nutrition, weight management and wellbeing solutions, traditional herbal remedies, and paediatric lines. These EZZ-branded items are sold directly to consumers via its e-commerce platforms and various retail stores, notably Tmall Global. Founded in 2015, EZZ Life Science Holdings Limited maintains its corporate headquarters in Silverwater, Australia.
Share Price
$0.21111796
Last synced: 2026-11-10
Market Cap
$9.93M
Change (1 day)
1.67%
Change (1 year)
-86.75%
Country
Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this
Trade EZZ Life Science Holdings Limited (EZZ)
Category
Healthcare
Operating Margin for EZZ Life Science Holdings Limited (EZZ)
Operating Margin as of November 2026 TTM: -14.28%
According to EZZ Life Science Holdings Limited's latest financial reports, its current operating margin (TTM) is -14.28%. At the end of 2025 the company had an operating margin of 14.85%.
Operating Margin history for EZZ Life Science Holdings Limited from 2019 to 2026
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2026 (TTM) | -14.28% | -196.16% |
| 2025 | 14.85% | 1.57% |
| 2024 | 14.62% | 17.62% |
| 2023 | 12.43% | 13.72% |
| 2022 | 10.93% | -5.29% |
| 2021 | 11.54% | 34.97% |
| 2020 | 8.55% | -18.73% |
| 2019 | 10.52% | 0.00% |
Operating Margin for similar companies or competitors
| Company | Operating Margin | Operating Margin Difference | Country |
|---|---|---|---|
| -181.36% | -87.30% |
US
|
|
| 38.59% | -102.70% |
US
|
|
| -149.01% | -89.57% |
US
|
|
| 25.57% | -101.79% |
AU
|
|
| 31.23% | -102.19% |
BE
|
What is a company's Operating Margin?
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.
Questions about EZZ Life Science Holdings Limited's operating margin
What is EZZ Life Science Holdings Limited's operating margin?
EZZ Life Science Holdings Limited's operating margin is -14.28%, as of Nov 2026.
What was EZZ Life Science Holdings Limited's operating margin in 2025?
In 2025, EZZ Life Science Holdings Limited's operating margin was 14.85%, compared with 14.62% in 2024.
How has EZZ Life Science Holdings Limited's operating margin changed since 2020?
From 2020 to 2025, EZZ Life Science Holdings Limited's operating margin was highest in 2025 (14.85%) and lowest in 2020 (8.55%).
How does EZZ Life Science Holdings Limited's operating margin compare with similar companies?
EZZ Life Science Holdings Limited's operating margin (-14.28%) is higher than that of 2 of the 5 similar companies listed above. The highest among them is Vertex Pharmaceuticals Incorporated, with 38.59%.